Logo     Print Page  Close Window


SEC Filings


8-K
FIBROCELL SCIENCE, INC. filed this Form 8-K on 05/10/2018
Entire Document
 
 
FCX-007 Interim Readout: Wound Healing • Digital images captured and tracings performed Post- Treated or Percent Healing Number of . Skin tattoos and transparent overlays used as landmarks Baseline Untreated Wounds Meeting Visit Wounds Criteria • Wounds monitored in the study prior to dosing were open 4 weeks Treated > 75% healed 100% (5/5) at each monitoring visit up to 8 months Untreated < 25% healed 80% (4/5) • A matched size untreated wound for each treated wound on the same patient was also monitored and evaluated 12 weeks Treated > 70% healed 80% (4/5)* • Compared to the baseline measurement collected at Day 0 Untreated < 25% healed 80% (4/5) pre-administration, wounds healing after a single injection session of FCX-007 resulted as follows: * Increase in size for one wound from the data set may have potentially destabilized due to biopsy samples collected in the center of the wound bed Day 0 Pre-Administration 4 Weeks 12 Weeks Treated area: 10.3cm2 Right posterior leg • White arrows denote tracking tattoo • Dash lines represent target treatment area • Day 0 pen markings denote injection locations • 4 week solid lines denote remaining wounded areas 75% healed 100% healed 11